mydecine

This Month in Psychedelics - August 2022

Policy

Following last month’s attempt to ban five novel psychoactive substances, which was later withdrawn, the DEA announced a plan to criminalize two additional psychedelic drugs—DOI and DOC. However, shortly after the announcement the DEA backed down and communicated that it no longer intends to place these two substances in Schedule I. While this may end up being a temporary victory, it is still a big win for now.

Industry

The psychedelic industry experienced a lot of movement this month. MindMed put an end to its 18-MC for opioid addiction program and slashed a lot of their early research and development projects. atai Life Sciences also decided to narrow its focus as well, cutting three programs: DemeRx’s noribogaine program, the non-psychedelic drug N-acetylcysteine for brain injury, and Salvinorin A for depression. And finally, Mydecine is looking like it is on the verge of closing due to a lack of funding.

Research

A randomized-clinical trial found that psilocybin-assisted psychotherapy is capable of treating alcohol use disorder. The study had a fairly small sample size of only 93 patients but the effect size was large, with the patients who received psilocybin reduced their drinking by 83% within eight months of their first dose.

Meanwhile, yet another placebo-controlled study found that psilocybin microdosing did not have any significant benefits to creativity, cognition, or perception. This study also had a small sample size, with only 34 participants, but it adds to the pile of evidence accumulating against the idea that microdosing has any tangible benefits that go beyond the placebo effect.

Miscellaneous

NFL football player Aaron Rodgers opened up about how he used ayahuasca to help him with his mental health and propel him to the point where he is at now in his career as the quarterback for the Green Bay Packers. This was a pretty big admission in the world of sports, where the use of illegal drugs is a big no-no. Fortunately both his coach and the league were accepting of the news, and hopefully this is the beginning of a trend because it would be great to see even more professional athletes come forward about their experiences with illegal drugs.

However, not all athletes got off so easy. WNBA star and two-time Olympic gold medalist Brittney Griner was sentenced to nine years in a Russian prison for the possession and smuggling of cannabis oil cartridges. Since then she has appealed the conviction and is hoping to overturn the ruling, but there’s no telling how this case will play out in court.

Wrapping up this month’s recap is a video of a wild bear who helped himself to a supply of psychedelic honey and ended up incapacitated in the back of a truck. Fortunately he turned out just fine after coming down from his trip, which I’m sure he’ll remember for the rest of his life!

That’s all for this month’s update. Remember to always test and weigh your drugs and until next time—keep thinking wilder.

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Weekly Psychedelic Links - August 2022

8.5.22

Cannabis

  • Brittney Griner sentenced to 9 years in Russian prison for drug possession and smuggling (Leafly)

  • Another American Caught With Weed in Russia Sentenced to 14 Years in Prison (High Times)

  • Cannabis no more of a risk than tobacco and alcohol – study (Cannabis Health News)

  • Federal Marijuana Records Would Be Expunged Under New Bipartisan Congressional Bill (Marijuana Moment)

  • New Study Says Legalization Hasn’t Caused More Teens To Try Cannabis (Marijuana Moment)

  • Cannabis Cafes Emerge in Post-Legalization Thailand (High Times)

  • Study Shows Cannabis Users 55% Less Likely to Develop Common Liver Cancer (High Times)

  • Arkansas Marijuana Campaign Files Lawsuit To Put Legalization Measure On Ballot After State Board’s Rejection (Marijuana Moment)

  • US weed homegrowers produce 8x more than Colorado legal market, says new report (Leafly)

  • Feds Seek Contractor To Help Test Marijuana Compounds In People’s Breath (Marijuana Moment)

  • New 3D Structures of Cannabinoid Receptor Inform Safer Drug Design (Psychedelic Science Review)

  • New Report Recommends Tips for Successful Cannabis-Impaired Driving Campaigns (High Times)

  • Colleges In States That Legalize Marijuana See A Boost In Application Numbers, Study Finds (Marijuana Moment)

  • Brazilian Government’s Selective Blindness to Cannabis Evidence (TalkingDrugs)

  • Largest Federal Workers Union Calls For Ending Marijuana Tests For Most Government Employees In Legal States (Marijuana Moment)

LSD

Magic Mushrooms

  • Psilocybin Microdosing Shows No Benefit to Creativity, Cognition, Perception in New Scientific Study (Willamette Week)

  • Oregon Psilocybin Rules Set To Be Finalized in December (High Times)

  • Lead Plaintiff in Canadian Right To Try Lawsuit Shares His Psilocybin Story (Lucid News)

  • The Rise of Casual Shrooms (VICE)

MDMA

  • It’s Festival Season! How Should We Group Dose MDMA? (Lucid News)

DMT

Ayahuasca

Mescaline

  • Mescaline: A Neglected Tool for Psychotherapy (Sam Woolfe)

Peyote

  • The Peyote Plot: The Indigenous Fight to Conserve the Sacred Plant and the Spiritual Medicine it Contains (DoubleBlind)

Synthetic Cannabinoids

Ketamine

  • Double-action mechanism found that makes ketamine less addictive (New Atlas)

  • How ketamine chic became the new heroin chic (Dazed)

Miscellaneous

  • Poll States 28% of Americans Have Tried At Least One Psychedelic Substance (High Times)

  • The Need for 100,000 Psychedelic Facilitators is Real (LA Weekly)

  • Morgan Stanley Publishes Optimistic Report on Psychedelics (Psychedelic Alpha)

  • California Bills To Legalize Psychedelics Possession, Allow Interstate Marijuana Commerce And More Teed Up For Key Hurdle Next Week (Marijuana Moment)

  • MindMed Board of Directors Approves Reverse Share Split (Psychedelic Alpha)

  • Majority Of Americans Support Psychedelics Research For Military Members, New Poll Finds As Bipartisan Reform Advances In Congress (Marijuana Moment)

8.12.22

Cannabis

  • Report: Spike in Marijuana Positives Fueling Truck Driver Shortage, Supply Chain Disruptions (NORML)

  • Ottawa on track to spend $200M per year on cannabis for veterans (CBC)

  • Wisconsin Governor Pardons Several for Cannabis Offenses (High Times)

  • Missouri will vote on marijuana legalization in November (Leafly)

  • Arkansas Supreme Court Orders State To Put Marijuana Legalization Initiative On Ballot, But Votes May Not Be Counted (Marijuana Moment)

  • Colorado Marijuana Shops Are 98 Percent Compliant With ID Checks To Prevent Underage Sales, State Regulators Say (Marijuana Moment)

  • Cannabis And Lower COVID Hospitalizations: Is There A Connection? Here’s What A New Study Found (The Fresh Toast)

  • Biden DOJ Says Medical Marijuana Patients Are Too ‘Dangerous To Trust’ In Motion To Dismiss Lawsuit On Gun Rights (Marijuana Moment)

  • Voters Across Wisconsin Will See Marijuana Questions On Their Ballots In November (Marijuana Moment)

  • ‘Very good for tourists’: Thailand aims for high season with U-turn on cannabis (The Guardian)

  • The (Possibly) Best and Worst Countries To Get Caught With Pot (Benzinga)

  • New Florida Marijuana Legalization Initiative Filed For 2024 Ballot, With Backing Of State’s Largest Medical Cannabis Company (Marijuana Moment)

  • Can memory loss be good? How cannabis can help with PTSD (Leafly)

  • Arresting illicit weed sellers repeats our drug war mistakes (NJ.com)

LSD

  • Neuroscience research suggests LSD might enhance learning and memory by promoting brain plasticity (PsyPost)

Magic Mushrooms

  • Psilocybin therapy is prompting states to reconsider laws about magic mushrooms (USA Today)

  • Many Oregonians will have to vote again on psilocybin (Oregon Capital Chronicle)

  • Buried Treasure: How Does Psilocybin Reduce Compulsivity? (Psychedelic Science Review)

  • Can Psilocybin Treat Obesity? New Evidence, Future Directions (Psychedelic Science Review)

  • Inside the lab that's creating enough psilocybin for everyone on Earth (Wisconsin Public Radio)

  • Phase 2 clinical trial to examine efficacy of psilocybin for anorexia nervosa (Healio)

  • Coos County cities move to ban psilocybin for medical use in their communities (KCBY)

  • Optimi Health To Launch Therapeutic Psilocybin Product In Partnership With Patient Advocate Thomas Hartle (Psychedelic Alpha)

MDMA

  • Las Vegas Wastewater Study Finds Absolutely Bonkers Spike In MDMA Levels During EDC (BroBible)

  • Where Ecstasy Meets Power: The Unique Risks of MDMA Therapy (Sam Woolfe)

Ayahuasca

  • Packers’ Aaron Rodgers Won’t Be Disciplined for Using Psychedelic Drug (Sports Illustrated)

  • Aaron Rodgers’ former Packers QB coach reacts to psychedelic drug revelation (New York Post)

Novel Psychoactive Substances

  • Psilera’s New Compounds Show Potential for Significant Treatment Improvement in Depression and Neurodegenerative Disorders (Psychedelic Alpha)

  • Majority of 'Bath Salt' Deaths Concentrated in Just Two States (Medpage Today)

  • Woman likely drowned after taking hallucinogenic drugs, coroner finds (Stuff.co.nz)

Synthetic Cannabinoids

  • States That Legalize Marijuana See ‘Significant Reductions’ In Synthetic Cannabinoid Poisonings, Study Finds (Marijuana Moment)

  • A 'very unpleasant time' - new synthetic drug in NZ (Radio New Zealand)

Nitrous Oxide

  • Urgent warning to parents over teens inhaling nitrous oxide after canisters found across Dublin (The Irish Sun)

Ketamine

  • How The Brain Changes In People With Chronic PTSD Following Ketamine Treatment (Healing Maps)

Miscellaneous

  • VR is as good as psychedelics at helping people reach transcendence (Technology Review)

  • The DARE Program Is Back in Some School Districts — Here’s What to Know (Teen Vogue)

  • Compass Pathways Sued for Stealing Trade Secrets (Psychedelic Spotlight)

  • An initiative to decriminalize most plant-based psychedelics is likely to fall short on signatures (Colorado Public Radio)

  • Colombia’s New President Wants to End the Drug War. Can He Succeed? (Filter)

  • Bear high on hallucinogenic 'mad honey' rescued in Turkey (Irish Mirror)

  • How Do We End the ‘War on Drugs’? Perhaps Scandinavia Has the Answer.. (Volteface)

  • Psychedelics are having a moment and women could be the ones to benefit (MIT Technology Review)

  • Over the counter culture: Are psychedelics coming to the corner shop? (The Independent)

  • Psychedelics researchers and investors should focus on delivering therapy, not drugs (STAT)

  • Muslims on Drugs: Psychedelics, Queerness, and Identity in the Post-9/11 Era (DoubleBlind)

  • What Role does Philosophy Play in the Future of Psychedelics? (TalkingDrugs)

  • First Reddit Community-Led Scientific Study to Launch on Quantified Citizen (Yahoo!)

  • Red Wall Voters Want Drug Law Reform – New Polling Shows (Volteface)

  • Psychedelic Clinical Trials and the Michael Pollan Effect (Psychedelic Spotlight)

  • Young Psychedelic Philanthropist Blazes Path for the Psychedelic Future (Lucid News)

  • Rediscovering Our Ancestral Roots of Exploration (Chacruna)

  • What Happens when Psychedelics Meets Video Games? (Lucid News)

8.19.22

Cannabis

  • Brittney Griner Appeals Conviction in Russian Drug Case (High Times)

  • North Dakota will vote on cannabis legalization in November (Leafly)

  • Arkansas court orders recreational cannabis amendment put back on ballot (Marijuana Business Daily)

  • Pot-smoking tourists not welcome in Thailand, says health minister (Reuters)

  • South Dakota Reservation Bans Alcohol, Allows Cannabis (High Times)

  • Analysis: Racial Disparities in Marijuana Possession Arrests Becoming More Pronounced in Prohibition States (NORML)

  • ‘Clean weed’ is about to be everywhere in California. Here’s what you need to know (Los Angeles Times)

  • Ohio Voters In Seven More Cities Will Decide On Marijuana Decriminalization At The Ballot This November (Marijuana Moment)

  • Idaho Activists Launch Medical Marijuana Ballot Push For 2024 (Marijuana Moment)

  • Alberta cannabis sales slow to grow as online identity verification deters consumers, say retailers (CBC)

  • Gallup: Those with First-Hand Experience with Cannabis Likely to Perceive It Positively (NORML)

  • Majority Of Texas Voters Support Marijuana Legalization, Poll Finds (Marijuana Moment)

  • Most Wisconsin Voters—Including Republicans—Support Legalizing Marijuana, Poll Shows (Marijuana Moment)

Magic Mushrooms

  • Is Oregon Ready for the Coming Psilocybin-Fueled Mushroom Tourism Boom? (Portland Monthly)

  • Optimi Health Unveils Canada’s First Natural Therapeutic Psilocybin Product For Approved Patients (Psychedelic Alpha)

MDMA

  • Warnings over dangerously high-strength MDMA pills found at Boardmasters (Mixmag)

DMT

  • Small Pharma Receives Approval for DMT-Assisted Psychotherapy and SSRI Drug Interaction Study (Psychedelic Alpha)

Ayahuasca

  • The Misfortune of “Right Wing” Psychedelia” in Brazil (Chacruna)

  • Anonymous Letter to Conservative Masters of the UDV (Chacruna)

Novel Psychoactive Substances

Nitrous Oxide

  • Atlanta neighbors frustrated by nitrous oxide use outside Widespread Panic show (KMIZ)

Ketamine

  • We Asked the Experts: What Exactly is in Ketamine? (TalkingDrugs)

Miscellaneous

  • Video of a forester who found a drunken bear gorged on hallucinogenic honey became a hit on the Internet (The Saxon)

  • California Psychedelics Legalization Bill Gutted by Key Committee (DoubleBlind)

  • Psychedelics as a sacrament? Lawsuit says drugs are a religious right. (The Washington Post)

  • Integration of psychedelic experiences linked to self-actualization via improvements in personal development and self-insight (PsyPost)

  • Two In Five Americans Say They’ve Changed Their Mind On Drug Policy, With Most Becoming “More Liberal,” Poll Finds (Marijuana Moment)

8.26.22

Cannabis

  • Federal Trade Commission issues refunds to CBD buyers, here’s why (Leafly)

  • Nebraska Officials Will Take A Second Look At Signatures For Rejected Medical Marijuana Ballot Measures (Marijuana Moment)

  • New medical marijuana campaign launches in Idaho for 2024 ballot (Marijuana Business Daily)

  • Study Shows 20% Increase in Frequency of Cannabis Consumption in Recreational States (High Times)

  • FBI Says CBD Use Is An ‘Automatic Disqualifier’ For Employment Despite Federal Hemp Legalization (Marijuana Moment)

  • Oklahoma’s legalization initiative at risk due to state delay (Leafly)

  • The casualties of California legalizing pot: Growers who went legal (The Washington Post)

  • U.S. Forest Service Reminds Workers Of Federal Marijuana Ban And Warns Against CBD Use (Marijuana Moment)

  • Dennis Rodman Proposes To Negotiate Russia Brittney Griner Release (High Times)

  • Why The Legal Cannabis Industry Needs The Black Market (Forbes)

  • Legalization Opponents Sue To Block Initiative From Missouri Ballot (High Times)

  • Cannabis for Chronic Pain Linked to Slightly Increased Risk of Arrhythmia (Healthline)

LSD

  • First Patient Dosed in Trial of LSD for Generalized Anxiety Disorder (Psychiatric Times)

Magic Mushrooms

  • Psilocybin May Help Treat Alcohol Addiction, Study Shows (TIME)

  • Three Out Of Four Oregon Counties Will Vote On Banning Or Postponing Psilocybin Services This November (Marijuana Moment)

  • Inside Paul Stamets’ Massive Microdosing Study (DoubleBlind)

Ayahuasca

  • Mormon Bishop And Former GOP Utah Rep. Champions Ayahuasca After Faith-Affirming Psychedelic Experience (Marijuana Moment)

5-MeO-DMT

  • Trip Advisors: Group Promotes 5-MeO-DMT Harm Reduction By Exposing Shamanic Hustlers (Forbes)

Novel Psychoactive Substances

  • The DEA is Attempting to Ban Two New Psychedelic Drugs (Psychedelic Spotlight)

  • Clearmind Medicine Announces Additional Positive Pre-Clinical Results for its Cocaine Addiction Treatment (Psychedelic Alpha)

  • BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity with Possible Nootropic Effects Similar to That of LSD Without Hallucinogenic Side Effects (Psychedelic Alpha)

Nitrous Oxide

  • Laughing Gas During Labor Is Becoming More Popular Among Women in the United States (People)

Ketamine

  • Ketamine’s upgrade to an employee benefit in US may hasten the legitimacy of psychedelics in SA (BizNews)

DXM

  • FDA Approves First, Only NMDA Receptor Antagonist for Major Depressive Disorder (Pharmacy Times)

Miscellaneous

  • Psychedelic Stocks: MindMed and atai Slash their Pipelines, Mydecine Collapses (Psychedelic Spotlight)

  • Psychedelics Use Increasing Among Adults, But Decreasing For Teens, New Federally Funded Studies Find (Marijuana Moment)

  • Psychedelic-occasioned mystical experiences linked to increased pro-environmental behaviors (PsyPost)

  • How near-death experiences and psychedelics alter attitudes about death (EurekAlert!)

  • Does Microdosing Actually Work? The Science Is Still Conflicted (VICE)

  • Issues of Patient Safety and Ethical Violations in Psychedelic Therapy (Psychedelic Science Review)

  • As Plant-Medicine Churches Grow, Legal Questions Linger (Lucid News)

  • This Psychedelic Theater Troupe Has Been Quietly Changing the World for Decades (DoubleBlind)

  • Do Psychedelic Trips Actually Start In The Gut Instead Of The Brain? (Healing Maps)

  • The Psychedelic Community Takes Itself Too Seriously (Psychedelic Alpha)

  • Ethics in Psychedelic Therapy: The Promises and Pitfalls of Increased Suggestibility (Sam Woolfe)

  • Do You Even Trip, Bro? On Psychedelic Masculinity (Psychedelic Spotlight)

  • How Long Can the Psychedelic Renaissance Last? (Psychedelic Spotlight)

  • The Legal Risks of Psychedelic Therapy and Coaching (EntheoNation)

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

Weekly Psychedelic Links - July 2022

7.1.22

Cannabis

  • Fentanyl-laced marijuana is a myth. It’s time to end the hype (Leafly)

  • Medical Weed Cards No Longer Required in Virginia Starting July 1 (High Times)

  • Hemp, CBD get permanent legal status in NC after 11th-hour rescue (MSN.com)

  • Scientists find THC in over 60% of CBD products they tested — and that may be a huge problem (ZME Science)

  • UN Report Dramatizes Uptick in Global Cannabis Use (High Times)

  • Louisiana Governor Signs Bill Providing Medical Marijuana Workplace Protections For State Employees (Marijuana Moment)

  • Maryland Court: Cops Can Stop, Question Someone Who Smells of Pot (High Times)

  • Nevada Cannabis Consumption Lounges Could Go Live By End Of 2022 (Marijuana Moment)

  • Edibles, beverages infused with cannabis ingredient THC become legal Friday in Minnesota (Star Tribune)

  • Inside The Process To Legalize Recreational Cannabis In Germany (Forbes)

  • California Bill to Require Cannabis Warnings About Mental Disorder Risks Advances (High Times)

  • Pennsylvania Lawmakers Advance Medical Marijuana DUI Protections And Cannabis Banking Reform Bills (Marijuana Moment)

  • Texas Supreme Court Bans Smokable Hemp Production, Sales (High Times)

  • Montana Lawsuit Challenges Marijuana Ban In State’s Third-Largest City (Marijuana Moment)

  • House Panel Approves Amendment to Protect State Legal Cannabis Programs (High Times)

  • Feds Fund Development Of Hemp-Based, 3D-Printed Materials To Build Affordable Housing (Marijuana Moment)

  • New Vermont Guidance Looks to Eliminate Plastic Waste From State’s Cannabis Industry (High Times)

  • Cannabis users are at greater risk for emergency and inpatient care: study (Fox News)

Magic Mushrooms

  • These Mormons Have Found a New Faith — in Magic Mushrooms (Rolling Stone)

  • New Jersey Senate President Files Psilocybin Legalization Bill That Includes Home Grow Option, Unlike Current Marijuana Law (Marijuana Moment)

  • Tryp Therapeutics Strengthens IP Portfolio with Provisional Patent Application for Binge Eating Disorder Treatment (Psychedelic Alpha)

  • Digging Up Druggable Targets: Psilocybin Efficacy in a Model of OCD (Psychedelic Science Review)

MDMA

  • First-of-its-kind MDMA group therapy trial set to commence (New Atlas)

  • Over One Hundred Years of MDMA Research (Drug Science)

Ayahuasca

  • How the Shipibo Came to Be the Most Common Group Serving Ayahuasca to Foreigners (DoubleBlind)

Peyote

  • Decriminalize Nature Targets Peyote: Drug Reform or Settler Colonialism? (Chacruna)

  • Big business could wipe out Mexico’s sacred psychedelic peyote cactus (openDemocracy)

Novel Psychoactive Substances

  • How Did A Minnesota Honor Roll Student Die As Her Parents Were Sleeping Upstairs? (Oxygen)

Synthetic Cannabinoids

  • A Loophole in Japan’s Weed Laws Is Getting Tens of Thousands High (VICE)

Miscellaneous

  • Colorado Activists Turn In Signatures To Put Psychedelics Legalization And Therapeutic Psilocybin Program On Ballot (Marijuana Moment)

  • War on drugs prolonged Colombia’s decades-long civil war, landmark report finds (The Guardian)

  • Is there a future for psychedelic treatment in Saudi Arabia? (Arab News)

  • Do Bad Psychedelic Patents Matter? (Lucid News)

  • 4 Recommendations for Disability Inclusion in Psychedelic Therapy Research (Psychiatric Times)

7.8.22

Cannabis

  • WNBA Star Brittney Griner Pleads Guilty To Cannabis Charge As Russia Calls Out U.S. Hypocrisy In Maintaining Criminalization (Marijuana Moment)

  • Make no mistake, marijuana edibles are legal now in Minnesota (Leafly)

  • Washington, D.C. Mayor Signs Medical Cannabis Self-Certification Bill (High Times)

  • Pennsylvania Bill Gives Medical Cannabis Patients DUI Protection (High Times)

  • Oklahoma: Advocates Turn in Signatures to Place Adult-Use Legalization Measure on November Ballot (NORML)

  • Study Shows Flower Still Reigns Supreme in U.S., Canada as Consumer Favorite (High Times)

  • Arkansas Activists Set To Turn In Double The Signatures Needed To Put Marijuana Legalization On Ballot (Marijuana Moment)

  • Nebraska Medical Marijuana Activists Turn In Ballot Signatures After Campaign Suffers Legal Setback (Marijuana Moment)

  • Albania Prompted to Implement Medical Cannabis Reform After U.N. Criticism (High Times)

  • U.S. Army Wants To Make Sniper Uniforms Out Of Hemp (Marijuana Moment)

LSD

  • A man whose daily headaches felt like an ice pick in his eyes says he tried 12 treatments but only found relief after taking LSD (Insider)

Magic Mushrooms

  • New Study Shows Mood, Mental Health Improved by Microdosing Psilocybin (High Times)

  • Indiana Nurse Faces Ten Years in Prison for Microdosing Psilocybin Mushrooms (Psychedelic Spotlight)

  • Two Cancer Patients Battle to Make Psilocybin Accessible for Palliative Care (Scientific American)

  • Rural Oregon counties are lining up against psilocybin launch (OPB)

MDMA

  • Alexandria Ocasio-Cortez Pushes for Psychedelic Reform in Congress (DoubleBlind)

  • GOP Congressman’s Amendment Would Direct Military To Study Psilocybin And MDMA Benefits For Service Members (Marijuana Moment)

DMT

  • Algernon Pharmaceuticals Provides Update on Its Phase 1 DMT Stroke Study (Psychedelic Alpha)

Iboga

  • ‘To Heal and to Care for’: Protecting Iboga and Indigenous Voices in the Face of Corporatisation (Volteface)

Novel Psychoactive Substances

  • DEA Announces Hearing On Proposed Ban Of Five Psychedelic Compounds Following Significant Pushback (Marijuana Moment)

  • Mindset Pharma Receives Allowance for Patent Application Covering its Short-Duration Novel Psychedelic Medications for The Treatment of Central Nervous System Disorders (Psychedelic Alpha)

Ketamine

  • PharmaTher Announces Positive Results from Study For Ketamine Microneedle Patch (Psychedelic Alpha)

Miscellaneous

  • The Never-Ending Psychedelic Trip of Michael Pollan (Rolling Stone)

  • Journey Colab scores $12M to move psychedelics-based addiction treatment into clinic (Fierce Biotech)

  • User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study (Drug Science)

  • Tripping the Reward Circuit: Psychedelics for Substance Use Disorders (Psychedelic Science Review)

  • Psychedelics Give a Glimpse of Enlightenment (Psychology Today)

7.15.22

Cannabis

  • Feds Must Defend Historical Rationale Of Banning Guns For Medical Marijuana Patients, Revised Lawsuit Argues After SCOTUS Ruling (Marijuana Moment)

  • ‘Green way of life’: Thailand sees cannabis boom after law change (Al Jazeera)

  • Washington DC just legalized weed for all adults—but it’s locals only (Leafly)

  • Oklahoma, North Dakota, Arkansas, and Nebraska submit signatures to put cannabis on November ballot (Leafly)

  • Study Shows Decrease in Heavy Truck Crash Rates Since Cannabis Legalization (High Times)

  • NYPD Will Keep Testing Officers For Marijuana, Reversing Course Hours After Announcing Policy Change Mandated By City (Marijuana Moment)

  • Cannabis Laws in France Have Disproportionately Affected Muslims (High Times)

  • New York Firefighters Won’t Be Tested For Marijuana, Department Says Following NYPD Leak (Marijuana Moment)

  • Argentine Supreme Court Endorses Medical Cannabis Home Grow (High Times)

  • Pennsylvania Governor Signs Marijuana Banking And Insurance Reform Bill Into Law (Marijuana Moment)

  • Portland Weed Demand Hits Three-Year Low (High Times)

  • Pennsylvania Police Arrested Over 13,000 People for Marijuana Possession in 2021 (NORML)

  • The Fight for Medical Cannabis in Indonesia (High Times)

  • Weed, Like Change, Nourishes The Soil To Regenerate The Cannabis Industry (Forbes)

LSD

  • Why David Bowie wasn’t a fan of LSD (Far Out)

Magic Mushrooms

  • DEA May Find Itself In Federal Court Again Over Refusal To Provide Psilocybin Access To Terminally Ill Patients (Marijuana Moment)

  • Oregon therapeutic psilocybin program sparks some confusion (OPB)

MDMA

  • World's first ecstasy 'shop' set to trial in the Netherlands (Mixmag)

  • Luxury Champagne Recalled Again Over Ecstacy Contamination (Newsweek)

  • MDMA: Rolling from Counterculture to the Clinic Counter (Psychedelic Science Review)

Ayahuasca

  • Study suggests ayahuasca users tend to eat healthier, get more exercise, and experience physical and mental health benefits (PsyPost)

Ketamine

  • PharmaTher Announces Notice of Allowance for U.S. Patent Covering Ketamine for the Potential Treatment of Parkinson’s Disease and Motor Disorders (Psychedelic Alpha)

Miscellaneous

  • Ann Shulgin, Forerunner of Today's Psychedelic Re-Emergence, Dies at 91 (Transform Press)

  • House Approves Marijuana And Psychedelics Amendments As Part Of Must-Pass Defense Bill (Marijuana Moment)

  • What Ethnographers Have Learned from People Who Use Drugs (Undark)

  • Inside the Chemistry Lab Where the MDMA Godfather Synthesized Novel Psychedelics (DoubleBlind)

  • The Tory Leadership Candidates on Drugs (Volteface)

  • Filament Health Issued Third Patent By United States Patent and Trademark Office (Psychedelic Alpha)

  • Doctors Urge Access to Psychedelic Therapies in New Mexico (TIME)

  • Can Psychedelics Treat Inflammation and Eye Disease? Eleusis Thinks So. (Lucid News)

  • Villain Or Victim? Understanding The Role of Women In The Latin American Drug Trade (TalkingDrugs)

  • San Francisco’s New DA Vows to Ramp Up City’s Drug War (Filter)

  • The Battle for Psychedelic Patents (Psychedelic Spotlight)

  • How To Become a Psychedelic Therapist (DoubleBlind)

  • 5 Countries Where Psychedelics are Legal (Psychedelic Spotlight)

7.22.22

Cannabis

  • Senate Leadership Introduces Legislation to End Federal Marijuana Prohibition (NORML)

  • District of Columbia: Mayor Signs Legislation Prohibiting Most Employers from Discriminating Against Cannabis Consumers (NORML)

  • Legal cannabis is producing more plastic waste than pot (Leafly)

  • Colorado Company To Research Cannabis As A Treatment For Parkinson’s Disease (Forbes)

  • Biden Says He’s ‘Working On’ Bill To Release Cannabis Inmates (High Times)

  • Germany, Luxembourg, Malta And The Netherlands Discuss Marijuana Legalization At Historic Joint Meeting (Marijuana Moment)

  • Colorado Springs Recreational Cannabis Initiative Qualifies for November Ballot (High Times)

  • Minnesota Is Home To America's First Cannabis Disc Golf Course (MIX 108)

  • House Passes Bill Permitting Weed Ads on TV and Radio (High Times)

  • Colorado's New Lead Marijuana Monitor Treks Through Heavy Issues (Westword)

  • Cannabis Telemedicine Launches in Montana (High Times)

  • Montana Marijuana Businesses Face Seemingly Endless Cycle Of Local Votes On Allowing Them To Operate (Marijuana Moment)

  • People Busted for Weed in the U.K. Could Lose Passports Under Proposed Rules (High Times)

  • Missouri Marijuana Legalization Measure In Danger Of Not Qualifying For Ballot (Marijuana Moment)

  • Denver officials want to save struggling cannabis delivery businesses (The Denver Post)

  • Study Finds Australians Support Cannabis Use Over Smoking Tobacco (High Times)

  • House Will Not Vote On Marijuana Amendments For Veterans And Public Housing Residents After Committee Snag (Marijuana Moment)

  • Marijuana use is higher among US states that have legalized recreational cannabis use (News-Medical)

LSD

  • The Doors of Expression: LSD Alters Epigenetics and Protein Induction (Psychedelic Science Review)

  • Science Feature: MindMed’s LSD Trial for ADHD (Microdose)

  • Watch John Lennon explain that 'Lucy in the Sky with Diamonds' was not about LSD (Far Out)

Magic Mushrooms

  • The Sloppy Science of Psilocybin Microdosing Surveys (Psychedelic Spotlight)

  • A single dose of psilocybin has long-lasting antidepressant-like effects in fruit flies (PsyPost)

  • Restrictions on Psilocybin ‘Magic Mushrooms’ Are Easing as Research Ramps Up (Scientific American)

MDMA

  • Patient safety issues halt trial for MDMA-assisted psychotherapy during Health Canada review (CBC)

  • 'Corrective' measures ordered, but Health Canada says 2nd MDMA trial can continue (CBC)

DMT

  • Teenager Used LSD And DMT To Help Overcome Trauma, Case Report Says (IFLScience)

Ayahuasca

  • Churches sue to use hallucinogenic tea in religious practice (UPI)

  • The Global Ayahuasca Boom: What About the Conservation of the Ayahuasca Vine? (Chacruna)

5-MeO-DMT

  • The Story Behind a 1984 Hallucinogenic Pamphlet From Denton Is Just as Trippy as Its Subject (Dallas Observer)

Novel Psychoactive Substances

  • Mydecine Files Full Patent Application Covering MYCO-006 Family of Novel Short-Acting MDMA Analogs (Psychedelic Alpha)

Synthetic Cannabinoids

  • Weed vapes probably sending a toxic gas to your lungs, study finds (Salon)

  • Cannabis getting stronger with synthetic versions added leading to psychosis, report warns (Independent.ie)

Ketamine

  • Largest-ever clinical study of ketamine therapy shows that at-home model can be a safe, effective treatment for anxiety and depression; 62% fewer patients report suicidal ideation after four sessions (PR Newswire)

  • Ketamine Beneficial For Treating Neonatal, And Pediatric Epilepsy: Study (Medical Dialogues)

Miscellaneous

  • The Long, Strange Relationship Between Psychedelics and Telepathy (VICE)

  • DEA Sued Over ‘Unlawful’ Delays On Psychedelic And Marijuana Public Records Requests Through FOIA (Marijuana Moment)

  • Colorado Psychedelics Legalization Measure Qualifies for November Ballot (DoubleBlind)

  • Keeping the Hippie Dream Alive (The New York Times)

  • Accessibility Is Key for the Psychedelic Revolution (Pharmacy Times)

  • Podcast aims to raise awareness about future of psychedelic treatments (CBC)

  • Skip the trip – does the world need non-hallucinogenic psychedelics? (leafie)

  • New Regulations for Psychedelics? Here's What Investors Need to Know (The Motley Fool)

7.29.22

Cannabis

  • Weedmaps again advertising illegal marijuana retailers and products, complaints allege (Marijuana Business Daily)

  • Singapore Executes Man for Cannabis Trafficking (High Times)

  • House Passes Bipartisan Marijuana Research Bill, With Senate Expected To Send It To President Soon (Marijuana Moment)

  • Zimbabwe OKs First Medicinal Cannabis Sales (High Times)

  • Secret Australian marijuana facility exposes location after turning sky pink (The Washington Post)

  • Biden Administration Proposes Prisoner Swap To Free Brittney Griner (High Times)

  • Over 850 Doctors in Thailand Protest Pot Legalization (High Times)

  • Senator Files Bill To Allow Marijuana Advertising On TV And Radio In Legal States (Marijuana Moment)

  • The 'World's Biggest Cannabis Scam' Is Totally Unravelling (VICE)

  • Bronx Cannabis Hub Fosters Opportunity in Communities Hit Hard by Arrests (Filter)

  • Cannabis Users Less Likely to Face Complications After Spinal Fusion Surgery (High Times)

  • 15 State Attorneys General File Brief Opposing Lawsuit To Help Put Medical Marijuana On Nebraska Ballot (Marijuana Moment)

  • Thai businesses cash in on cannabis, from milk tea to toothpaste (Reuters)

  • Missouri Marijuana Legalization Initiative Short Of Signatures Needed For Ballot In County Reviews (Marijuana Moment)

  • New Hampshire stands alone in New England as only state without legal marijuana (WMUR)

LSD

  • New Zealand Government Grants $650K For LSD Microdosing Trials (Benzinga)

  • Operation Julie: Rural Wales LSD bust becomes a musical (BBC)

Magic Mushrooms

  • DEA Sued Again Over Refusal To Allow Psilocybin Access For Patients Despite Federal Law (Marijuana Moment)

  • Why some of Colorado’s foremost shrooms advocates won’t be voting to legalize psilocybin (The Denver Post)

  • Legal psilocybin prescriptions in Canada (Drug Science)

  • Project Solace: The World’s Largest Medical Psilocybin Access and Data Project (Psychedelic Spotlight)

  • COMPASS Pathways launches phase II clinical trial of psilocybin therapy in anorexia nervosa (Psychedelic Alpha)

DMT

  • U.S. Patent Grant to Strengthen Small Pharma’s DMT Patent Strategy With Injectable Formulation (Psychedelic Alpha)

Novel Psychoactive Substances

  • DEA Cancels Proposed Ban Of Five Psychedelics, Giving Scientists More Time To Research Therapeutic Benefits (Marijuana Moment)

  • Working with Indigenous allies is the ethical way to develop psychedelic-based pharmaceuticals (STAT News)

  • Festival drugs: Warning over 'imposter' substances threat (BBC)

  • Ecstasy for the 21st Century: Designer Drugs to Improve MDMA Therapy (Psychedelic Science Review)

Synthetic Cannabinoids

  • Easy On The Eyes — This Company Reports Using a Unique Synthetic Cannabinoid Derivative To Treat Glaucoma (Benzinga)

Nitrous Oxide

  • Doctors warn ‘dangerous’ laughing gas is becoming an ‘epidemic’ amid rise in hospitalisations (The Independent)

  • A Law will Prohibit the Sale of Nitrous Oxide or “Laughing Gas” to Minors in Bulgaria (Novinite.com)

Ketamine

  • At Home Sublingual Ketamine Exhibits Rapid And Significant Antidepressant And Anxiolytic Effects (Medical Dialogues)

  • Ketamine found to be unlikely to lead to addiction (Medical Xpress)

  • Silo Pharma Announces Positive Results from its Topically Administered Formulation of Ketamine (Psychedelic Alpha)

Miscellaneous

  • Biden Administration Plans For Legal Psychedelic Therapies Within Two Years (The Intercept)

  • San Francisco Launches Bid to Decriminalize Psychedelics (Filter)

  • Your Genes May Determine How You React To Psychedelic Drugs (IFLScience)

  • The Psychoactive Substances Act on Trial (Volteface)

  • The High-Stakes Race to Engineer New Psychedelic Drugs (WIRED)

  • Trump Urges ‘Very Quick Trial’ and Death Penalty for Drug Dealers (High Times)

  • The Psychedelics Industry’s Next Hurdle Is How to Go Mainstream (Bloomberg)

  • One in four Americans say they’ve tried at least one psychedelic drug (YouGov)

  • Microdosing: Scientists tackle psychedelic trend becoming ‘creative enhancer of choice’ (The Sydney Morning Herald)

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 1.14.22

Cannabis

  • Oregon State research shows hemp compounds prevent coronavirus from entering human cells (Oregon State University)

  • Polls Funded By Marijuana Prohibitionist Group Show Big Support For Legalization Policies It Lobbies Against (Marijuana Moment)

  • Top German Government Official Previews Marijuana Legalization Plan Details (Marijuana Moment)

  • First-dose vaccinations quadruple in Quebec ahead of restrictions at liquor and cannabis stores (CTV News)

  • Mississippi Senate Votes To Legalize Medical Marijuana, Defying Governor’s Veto Threat (Marijuana Moment)

  • Oregon: New Rules Increase the Amount of Cannabis Adults Can Purchase Per Transaction (NORML)

  • Ohio Marijuana Activists Turn In More Signatures For Legalization Initiative After Temporary Setback (Marijuana Moment)

  • Delaware Lawmakers File New Marijuana Legalization Bill With Key Equity Revisions (Marijuana Moment)

  • Kansas lawmaker wants to refer medical marijuana legalization to voters (Marijuana Business Daily)

  • Austin Officials Certify Local Marijuana Decriminalization Initiative For May Ballot (Marijuana Moment)

  • Wyoming Activists Prepare Cannabis Reform Initiatives (High Times)

  • Virginia Lawmakers Divided On Releasing Marijuana Prisoners Following Legalization Taking Effect (Marijuana Moment)

  • South Dakota Governor Wants Marijuana Activists To Pay Legal Bill For Her Lawsuit That Blocked Legalization (Marijuana Moment)

  • Florida Marijuana Activists Pivot To 2024 For Legalization Ballot Initiative (Marijuana Moment)

Magic Mushrooms

  • Global Coalition Launches Push To Reschedule Psilocybin Under International Rules (Marijuana Moment)

  • Italian Officials Certify Signatures For National Marijuana And Psilocybin Referendum (Marijuana Moment)

  • Rollups: The Emerging Magic Mushroom Monopoly (The American Prospect)

  • Numinus Submits Clinical Trial Application for Phase 1 Trial on Proprietary Psilocybin Product (Psilocybin Alpha)

  • Psilocybin Clinical Trial for Depression Launches at Pacific Neuroscience Institute (PR Newswire)

MDMA

  • MAPS Publishes Open Science Approach to Synthesizing MDMA (Lucid News)

Ayahuasca

  • A New Study Attempts To Quantify The Healing Powers Of Ayahuasca (Forbes)

Novel Psychoactive Substances

  • Mydecine Achieves Innovative Supercomputing Artificial Intelligence Modeling in Psychedelic Drug Development Enabling Quick Screening of Billions of Compounds (Psilocybin Alpha)

  • Field Trip Receives Notice of Allowance for US Patent Application Covering FT-104 (Isoprocin Glutarate), its Novel Psychedelic Molecule in Development (Psilocybin Alpha)

Ketamine

  • Trial of Ketamine Therapy for Alcohol Use Disorder Reports Positive Findings (Technology Networks)

  • Osmind Announces Publication of the Largest Real-World Analysis of Ketamine Infusion Therapy for Depression (Business Wire)

  • Institutional Review Board Grants Approval for Cybin-Sponsored Feasibility Study Using Kernel Flow Technology to Measure Psychedelic Effects on the Brain (Psilocybin Alpha)

  • Peter Thiel-Backed Psychedelics Company Gets FDA Approval To Study Ketamine Therapy (Forbes)

  • PharmaTher Announces FDA Approval of Investigational New Drug (IND) Application for Ketamine to Treat ALS (Psilocybin Alpha)

Miscellaneous

  • How Beer and Drugs Empowered an Ancient Andean Empire (Gizmodo)

  • These States Could Legalize Marijuana Or Psychedelics In 2022 (Marijuana Moment)

  • Virginia Could Decriminalize Psilocybin And Other Psychedelics With Newly Filed Bills (Marijuana Moment)

  • Social Media Attacks and Ethical Issues in the Psychedelic Sector — Why can’t we all get on together for the greater good? (Medium)

  • Missouri Patients Could Use Psychedelic Treatments Under New GOP ‘Right-To-Try’ Bill (Marijuana Moment)

  • ‘Microdosers’ of LSD and magic mushrooms are wiser and more creative (Daily Maverick)

  • Promising Psychedelic Therapy Legislation Set to Make Waves in 2022 (Psychedelic Spotlight)

  • Vermont Lawmakers File Drug Decriminalization Bill With Hopes Of Promoting Harm Reduction (Marijuana Moment)

  • Announcing a Major Healthy Persons Trial to Investigate the Brain Activity Effects of Psychedelic Medicines (Mind Medicine Australia)

  • University Of Ottawa To Offer Psychedelic Studies Master’s Program Beginning In Fall 2022 (Healing Maps)

  • The Connection between Psychedelics and Christianity (The Institute for the Advancement of Psychedelic Christianity)

  • Metaphysical Insight: Psychedelics, Noetic Experiences, and Spinoza’s God (Sam Woolfe)

  • How to Come Out to Your Kids About Psychedelics (DoubleBlind)

  • Psychedelics in Healthcare: The Psychedelic Pharmacists Association (Truffle Report)

  • Can Western Medicine Include the Sacred in Psychedelic-Assisted Psychotherapy? (Lucid News)

  • How To Vet Your Psychedelic Guide (DoubleBlind)

  • Mydecine to Launch Special Access Support and Supply Program in Canada Expanding Access to Psychedelic-Assisted Psychotherapy For Patients (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 10.29.21

Cannabis

  • With export restrictions eased, Colombia's medical cannabis business is poised for liftoff (CNN)

  • Federal Survey Identifies Marked Decline in Youth Marijuana Use (NORML)

  • Why did Texas ban Delta-8? (Popular Science)

  • Cannabis products may help treat symptoms of depression, improve sleep, and increase quality of life, study suggests (PsyPost)

  • California Destroys 1M Plants in Marijuana Eradication Campaign (High Times)

  • State Attorneys General Warn About Marijuana-Infused Candy And Snacks Ahead Of Halloween (Marijuana Moment)

  • The Myth of Cannabis-Infused Halloween Candy—Debunked (High Times)

  • Cannabis is one industry that's actually coming out of Covid even stronger (CNN)

  • South Dakota Lawmakers Approve Marijuana Legalization Bill As Activists Pursue 2022 Ballot Initiative (Marijuana Moment)

  • New York: Officials Moving to Clear Over 400,000 Past Marijuana Convictions (NORML)

  • Montana Supreme Court Unanimously Overturns a Pot Conviction, Saying Cops Stopped the Defendant for No Good Reason (Reason)

  • Analysis: ‘Government-Grade’ Marijuana More Closely Resembles Hemp, Has Little in Common with Commercially Available Cannabis (NORML)

  • Florida judge rules online marijuana ordering sites may resume business (Marijuana Business Daily)

  • Louisiana plans to regulate, not ban, delta-8 THC (Marijuana Business Daily)

  • Former Arkansas Lawmaker Launches Campaign To Put Marijuana Legalization On The 2022 Ballot (Marijuana Moment)

  • Maryland: Most Residents Want to Legalize Marijuana for Adult Use (NORML)

LSD

  • Ex-Denver Cop Who Broke Teen's Face for Dancing on LSD to Cost City $1.2 Million (Westword)

Magic Mushrooms

  • Study Finds Psilocybin Improves MDD in Patients With Cancer (Psychiatric Times)

  • Latest psilocybin patent highlights the swirling battle over psychedelics intellectual property (STAT)

  • Italian Activists Turn In More Than Half A Million Signatures For Marijuana And Psilocybin Referendum (Marijuana Moment)

  • Dr. Bronner’s Funds Psilocybin Legalization Effort in Connecticut (High Times)

  • More Evidence of the Chemical Compound Variability in Magic Mushrooms (Psychedelic Science Review)

  • MYND Life Sciences Signs Agreement to Acquire Rights for the Use of Psychedelics to Treat Alzheimer’s Disease and other Dementias (Psilocybin Alpha)

  • Nova Mentis Earns Psilocybin Orphan Drug Designation in Europe for Fragile X Syndrome (PR Newswire)

MDMA

  • No One Is Wasting Their Ecstasy on Your Kids' Halloween Candy (Reason)

  • MindMed Announces R(-)-MDMA Program to target Social Anxiety Associated with Autism Spectrum Disorder (Psilocybin Alpha)

Ayahuasca

5-MeO-DMT

  • Beckley Psytech Announces First Cohort Dosed in Phase 1 Clinical Trial Assessing Safety and Tolerability of Intranasal 5-MeO-DMT (Psilocybin Alpha)

Novel Psychoactive Substances

  • Mydecine Reports Successful Synthesis of Novel Tryptamine Improving the Pharmaceutical Properties of Psilocin (Psilocybin Alpha)

  • Silo Pharma Enters into Sponsored Research Agreement with Columbia University to Develop Psychedelic Therapeutics for Alzheimer’s Disease (Psilocybin Alpha)

  • Awakn Life Sciences Identifies New Chemical Series Via Its Drug Discovery Program (Awakn Life Sciences)

  • Marvel Biosciences Announces New Program to Develop Novel Orally Dosed Non-Hallucinogenic Neuroplastic Promoting Compounds (Yahoo! Finance)

Synthetic Cannabinoids

Ketamine

  • European Patent Grant Strengthens Small Pharma’s Ketamine-Based Patent Portfolio for the Treatment of Depressive Disorders (Psilocybin Alpha)

  • Cocaine, ketamine use on the rise: survey (PerthNow)

  • Cybin Announces FDA Investigational New Drug Authorization of Cybin’s Sponsored Feasibility Study Using Kernel Flow Technology (Psilocybin Alpha)

  • MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder into Clinics Across United States and Canada through iSTRYM, MINDCURE’s Digital Therapeutics Platform (Psilocybin Alpha)

Miscellaneous

  • Canadian entrepreneur gifts $5 million to help create psychedelic research centre for mental health (CTV News)

  • Where the Psychedelic Revolution Is Headed, According to the Guy Who (Arguably) Started It (GQ)

  • Psychedelics Group Issues First Round Of Grants For Community-Based Entheogenic Education In DC (Marijuana Moment)

  • Addressing Abuse in Psychedelic Spaces (Psychedelics Today)

  • North America Continues Leading The Way In Psychedelic Wellness (PR Newswire)

  • Psychedelic Patents Should Be Limited, Harvard Law Experts Say (Psychedelic Spotlight)

  • Could Psychedelics Cure Our Post-Pandemic Depression? (Truffle Report)

  • How Gender Affects the Way We Use Drugs (TalkingDrugs)

  • DC Voters Strongly Support Drug Decriminalization, Poll Finds As Activists Launch Campaign (Marijuana Moment)

  • MAPS Canada’s Data Breach Foreshadows Corporadelic Future (Psymposia)

  • Wavepaths: The Neuroscientist-Founded Company Producing Music For—And As—Psychedelic Therapy (Forbes)

  • Novamind Brings Contract Research To Psychedelic Medicine (Lucid News)

  • Psychedelic Research Beyond Depression & Trauma (Truffle Report)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.